Literature DB >> 8888373

Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole.

H Einat1, D Einat, M Allan, H Talangbayan, T Tsafnat, H Szechtman.   

Abstract

A pairing paradigm was employed to explore the contribution of associational mechanisms to the expression of sensitization to the dopamine agonist quinpirole. Rats received ten quinpirole injections in the test environment (Group Paired) or in the home cage (Group Unpaired), and saline in the alternate environment. A third group received saline injections in both environments (Group Acute). Subjects received quinpirole on the 11th injection as a test for locomotor sensitization, and saline on the next injection as a test for conditioned activity. The range of discriminative stimuli predicting a drug versus a non-drug injection was increased across three independent experiments in an effort to detect a possible associational effect. Regardless of the strength of discriminative stimuli, both Paired and Unpaired groups showed locomotor sensitization to 0.5 mg/kg quinpirole compared with the Acute group. However, the Paired group showed more locomotion than the Unpaired group in the last minutes of the sensitization test. With a lower sensitizing dose of quinpirole (0.1 mg/kg) used in one experiment, only the Paired group showed locomotor sensitization. For both doses, the Paired, but not the Unpaired groups showed conditioned locomotion. It is suggested that with moderate doses of quinpirole, expression of locomotor sensitization does not require drug-signalling cues though such signals may have a modulatory influence. With lower quinpirole doses, however, quinpirole sensitization is context-dependent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888373     DOI: 10.1007/bf02805980

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Extinction procedures abolish conditioned stimulus control but spare sensitized responding to amphetamine.

Authors:  J. Stewart; P. Vezina
Journal:  Behav Pharmacol       Date:  1991-02       Impact factor: 2.293

2.  Environmental influences on behavioural sensitization to the dopamine agonist quinpirole.

Authors:  P. Willner; M. Papp; S. Cheeta; R. Muscat
Journal:  Behav Pharmacol       Date:  1992-02       Impact factor: 2.293

3.  Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats.

Authors:  E J Mazurski; R J Beninger
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.

Authors:  L W Zhou; Z H Qin; B Weiss
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

5.  Morphine tolerance as habituation.

Authors:  T B Baker; S T Tiffany
Journal:  Psychol Rev       Date:  1985-01       Impact factor: 8.934

6.  Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats.

Authors:  D Eilam; K V Clements; H Szechtman
Journal:  Behav Brain Res       Date:  1991-11-26       Impact factor: 3.332

7.  Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization.

Authors:  R M Post; A Lockfeld; K M Squillace; N R Contel
Journal:  Life Sci       Date:  1981-02-16       Impact factor: 5.037

8.  Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole.

Authors:  H Szechtman; H Dai; S Mustafa; H Einat; R M Sullivan
Journal:  Pharmacol Biochem Behav       Date:  1994-08       Impact factor: 3.533

9.  Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats.

Authors:  H Einat; H Szechtman
Journal:  Behav Brain Res       Date:  1993-03-31       Impact factor: 3.332

10.  The development of behavioral sensitization to apomorphine is blocked by MK-801.

Authors:  J P Druhan; A Jakob; J Stewart
Journal:  Eur J Pharmacol       Date:  1993-10-12       Impact factor: 4.432

View more
  7 in total

Review 1.  Obsessive-compulsive disorder: Insights from animal models.

Authors:  Henry Szechtman; Susanne E Ahmari; Richard J Beninger; David Eilam; Brian H Harvey; Henriette Edemann-Callesen; Christine Winter
Journal:  Neurosci Biobehav Rev       Date:  2016-05-07       Impact factor: 8.989

2.  Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control.

Authors:  H Szechtman; M J Eckert; W S Tse; J T Boersma; C A Bonura; J Z McClelland; K E Culver; D Eilam
Journal:  BMC Neurosci       Date:  2001-04-12       Impact factor: 3.288

3.  Dopamine D2 agonist priming in intact and dopamine-lesioned rats.

Authors:  Richard M Kostrzewa; John P Kostrzewa; Przemyslaw Nowak; Rose A Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  PI3K activation within ventromedial prefrontal cortex regulates the expression of drug-seeking in two rodent species.

Authors:  Karen K Szumlinski; Alexis W Ary; Christina B Shin; Melissa G Wroten; Justin Courson; Bailey W Miller; Micaela Ruppert-Majer; John W Hiller; John R Shahin; Osnat Ben-Shahar; Tod E Kippin
Journal:  Addict Biol       Date:  2018-11-18       Impact factor: 4.280

5.  Multigenerational effects of adolescent morphine exposure on dopamine D2 receptor function.

Authors:  John J Byrnes; Nicole L Johnson; Lindsay M Carini; Elizabeth M Byrnes
Journal:  Psychopharmacology (Berl)       Date:  2013-01-13       Impact factor: 4.530

6.  Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.

Authors:  Ryszard Brus; Richard M Kostrzewa; Przemysław Nowak; Ken W Perry; John P Kostrzewa
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.

Authors:  Richard M Kostrzewa; Przemysław Nowak; Ryszard Brus; Russell W Brown
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.